2026 Legislative and Government Insights Landscape

IPD Analytics has released a new report, “2026 Legislative and Government Insights Landscape,” highlighting the policy developments that continue to shape U.S. healthcare. Key legal rulings, regulatory reforms, and state-level initiatives such as Prescription Drug Affordability Boards (PDABs) are influencing how drugs are priced, reimbursed, and accessed. The report explores how these actions are expected to increase regulatory complexity and transparency pressures in the year ahead. As stakeholders prepare for 2026, understanding these policy shifts will be critical to navigating pricing, reimbursement, and access strategies.